In The News

BioWorld: Truvian’s blood testing platform provides lab quality results

“BEING A LIFE SCIENCES LEADER” PODCAST FEATURING Brian Halak – Medical Excellence Capital

MEC Portfolio Company Aspen Neuroscience Featured in Wall Street Journal for Parkinson’s Disease Research

WALL STREET JOURNAL: The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure

ENDPOINT NEWS EXCLUSIVE: Sanofi, Astellas venture arms add cash to Avilar’s ‘ATAC’ mission

Endpoints News: A stem cell pioneer sent an experiment into space. Patients are the next frontier

BioCentury: BioCentury’s 2022 class of emerging companies

Endpoints News: Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform

BioCentury: Medical Excellence to fund cell, gene therapy, AI and regenerative medicine with $145M debut fund

Wall Street Journal: Life Sciences Venture Investor MEC Raises $145 Million Fund